Name | 4-[2-Methyl-1-(4-methyl-1-piperazinyl)-1-oxo-2-propanyl]-N-[6-(4-pyridinyl)imidazo[1,2-a]pyridin-2-yl]benzamide |
---|---|
Synonyms |
4-[2-Methyl-1-(4-methyl-1-piperazinyl)-1-oxo-2-propanyl]-N-[6-(4-pyridinyl)imidazo[1,2-a]pyridin-2-yl]benzamide
MFCD31689325 Benzamide, 4-[1,1-dimethyl-2-(4-methyl-1-piperazinyl)-2-oxoethyl]-N-[6-(4-pyridinyl)imidazo[1,2-a]pyridin-2-yl]- |
Description | CLK inhibitor T3 (T3) is a highly potent, selective, and cell-based stable CDC-like kinase (CLK) inhibitor with 0.67, 15 and 110 nM for CLK1,2 and 3, respectively; displays 200-300-fold selectivity over other dual specificity kinases such as DYRK1A and DYRK1B; induces dose-dependent reduction in exon recognition and exhibits an overlapping, but greater effect on transcriptome splicing compared to KH-CB19. |
---|---|
References | References 1. Funnell T, et al. Nat Commun. 2017 Feb 23;8(1):7. View Related Products by Target Cdc2-like Kinase (CLK) |
Density | 1.3±0.1 g/cm3 |
---|---|
Molecular Formula | C28H30N6O2 |
Molecular Weight | 482.577 |
Exact Mass | 482.243011 |
LogP | 2.36 |
Index of Refraction | 1.659 |